Review



mouse monoclonal antibody against dnmt1  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Novus Biologicals mouse monoclonal antibody against dnmt1
    Epithelial immunohistochemical expression of <t>DNMT1</t> at each exposure time. Main images were magnified at 100x and zoomed sub-image at 400x. Epithelial cells are stained in the nuclei in brown according to exposure period.
    Mouse Monoclonal Antibody Against Dnmt1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 123 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+anti+dnmt1/DNMT3B+Antibody/pmc13123776-57-6-14
    Average 93 stars, based on 123 article reviews
    mouse monoclonal antibody against dnmt1 - by Bioz Stars, 2026-10
    93/100 stars

    Images

    1) Product Images from "DNA methyltransferases expressions in mice tongue exposed to waterpipe smoke"

    Article Title: DNA methyltransferases expressions in mice tongue exposed to waterpipe smoke

    Journal: Journal of Applied Oral Science

    doi: 10.1590/1678-7765-2025-0665

    Epithelial immunohistochemical expression of DNMT1 at each exposure time. Main images were magnified at 100x and zoomed sub-image at 400x. Epithelial cells are stained in the nuclei in brown according to exposure period.
    Figure Legend Snippet: Epithelial immunohistochemical expression of DNMT1 at each exposure time. Main images were magnified at 100x and zoomed sub-image at 400x. Epithelial cells are stained in the nuclei in brown according to exposure period.

    Techniques Used: Immunohistochemical staining, Expressing, Staining

    Boxplots showing enzyme expression pattern according to exposure times (in days) on each tongue site for DNMT1 (a) and DNMT3b (b). The graphic presents the variable distribution of our data in a five number summary (minimum, first quartile, mean, upper quartile and maximum); circles=outliers; *=extreme outliers; †=statistically significant difference.
    Figure Legend Snippet: Boxplots showing enzyme expression pattern according to exposure times (in days) on each tongue site for DNMT1 (a) and DNMT3b (b). The graphic presents the variable distribution of our data in a five number summary (minimum, first quartile, mean, upper quartile and maximum); circles=outliers; *=extreme outliers; †=statistically significant difference.

    Techniques Used: Expressing

    Related Articles

    Recombinant:

    Article Title: PAI-1 uncouples integrin-β1 from restrain by membrane-bound β-catenin to promote collagen fibril remodeling in obesity-related neoplasms
    Article Snippet: Mouse monoclonal anti-DNMT1 , Novus Biologicals , Cat# NB100-56519; RRID: AB_2093819.

    Membrane:

    Article Title: PAI-1 uncouples integrin-β1 from restrain by membrane-bound β-catenin to promote collagen fibril remodeling in obesity-related neoplasms
    Article Snippet: Mouse monoclonal anti-DNMT1 , Novus Biologicals , Cat# NB100-56519; RRID: AB_2093819.

    Cell Culture:

    Article Title: PAI-1 uncouples integrin-β1 from restrain by membrane-bound β-catenin to promote collagen fibril remodeling in obesity-related neoplasms
    Article Snippet: Mouse monoclonal anti-DNMT1 , Novus Biologicals , Cat# NB100-56519; RRID: AB_2093819.

    Reverse Transcription:

    Article Title: PAI-1 uncouples integrin-β1 from restrain by membrane-bound β-catenin to promote collagen fibril remodeling in obesity-related neoplasms
    Article Snippet: Mouse monoclonal anti-DNMT1 , Novus Biologicals , Cat# NB100-56519; RRID: AB_2093819.

    SYBR Green Assay:

    Article Title: PAI-1 uncouples integrin-β1 from restrain by membrane-bound β-catenin to promote collagen fibril remodeling in obesity-related neoplasms
    Article Snippet: Mouse monoclonal anti-DNMT1 , Novus Biologicals , Cat# NB100-56519; RRID: AB_2093819.

    Clinical Proteomics:

    Article Title: PAI-1 uncouples integrin-β1 from restrain by membrane-bound β-catenin to promote collagen fibril remodeling in obesity-related neoplasms
    Article Snippet: Mouse monoclonal anti-DNMT1 , Novus Biologicals , Cat# NB100-56519; RRID: AB_2093819.

    Protein Extraction:

    Article Title: PAI-1 uncouples integrin-β1 from restrain by membrane-bound β-catenin to promote collagen fibril remodeling in obesity-related neoplasms
    Article Snippet: Mouse monoclonal anti-DNMT1 , Novus Biologicals , Cat# NB100-56519; RRID: AB_2093819.

    Extraction:

    Article Title: PAI-1 uncouples integrin-β1 from restrain by membrane-bound β-catenin to promote collagen fibril remodeling in obesity-related neoplasms
    Article Snippet: Mouse monoclonal anti-DNMT1 , Novus Biologicals , Cat# NB100-56519; RRID: AB_2093819.

    Bicinchoninic Acid Protein Assay:

    Article Title: PAI-1 uncouples integrin-β1 from restrain by membrane-bound β-catenin to promote collagen fibril remodeling in obesity-related neoplasms
    Article Snippet: Mouse monoclonal anti-DNMT1 , Novus Biologicals , Cat# NB100-56519; RRID: AB_2093819.

    In Situ:

    Article Title: PAI-1 uncouples integrin-β1 from restrain by membrane-bound β-catenin to promote collagen fibril remodeling in obesity-related neoplasms
    Article Snippet: Mouse monoclonal anti-DNMT1 , Novus Biologicals , Cat# NB100-56519; RRID: AB_2093819.

    Blocking Assay:

    Article Title: PAI-1 uncouples integrin-β1 from restrain by membrane-bound β-catenin to promote collagen fibril remodeling in obesity-related neoplasms
    Article Snippet: Mouse monoclonal anti-DNMT1 , Novus Biologicals , Cat# NB100-56519; RRID: AB_2093819.

    Migration:

    Article Title: PAI-1 uncouples integrin-β1 from restrain by membrane-bound β-catenin to promote collagen fibril remodeling in obesity-related neoplasms
    Article Snippet: Mouse monoclonal anti-DNMT1 , Novus Biologicals , Cat# NB100-56519; RRID: AB_2093819.

    shRNA:

    Article Title: PAI-1 uncouples integrin-β1 from restrain by membrane-bound β-catenin to promote collagen fibril remodeling in obesity-related neoplasms
    Article Snippet: Mouse monoclonal anti-DNMT1 , Novus Biologicals , Cat# NB100-56519; RRID: AB_2093819.

    Control:

    Article Title: PAI-1 uncouples integrin-β1 from restrain by membrane-bound β-catenin to promote collagen fibril remodeling in obesity-related neoplasms
    Article Snippet: Mouse monoclonal anti-DNMT1 , Novus Biologicals , Cat# NB100-56519; RRID: AB_2093819.

    Software:

    Article Title: PAI-1 uncouples integrin-β1 from restrain by membrane-bound β-catenin to promote collagen fibril remodeling in obesity-related neoplasms
    Article Snippet: Mouse monoclonal anti-DNMT1 , Novus Biologicals , Cat# NB100-56519; RRID: AB_2093819.

    Pyromark Assay:

    Article Title: PAI-1 uncouples integrin-β1 from restrain by membrane-bound β-catenin to promote collagen fibril remodeling in obesity-related neoplasms
    Article Snippet: Mouse monoclonal anti-DNMT1 , Novus Biologicals , Cat# NB100-56519; RRID: AB_2093819.

    Western Blot:

    Article Title: PAI-1 uncouples integrin-β1 from restrain by membrane-bound β-catenin to promote collagen fibril remodeling in obesity-related neoplasms
    Article Snippet: Mouse monoclonal anti-DNMT1 , Novus Biologicals , Cat# NB100-56519; RRID: AB_2093819.

    Simple Western:

    Article Title: PAI-1 uncouples integrin-β1 from restrain by membrane-bound β-catenin to promote collagen fibril remodeling in obesity-related neoplasms
    Article Snippet: Mouse monoclonal anti-DNMT1 , Novus Biologicals , Cat# NB100-56519; RRID: AB_2093819.



    Similar Products

    93
    Novus Biologicals mouse monoclonal antibody against dnmt1
    Epithelial immunohistochemical expression of <t>DNMT1</t> at each exposure time. Main images were magnified at 100x and zoomed sub-image at 400x. Epithelial cells are stained in the nuclei in brown according to exposure period.
    Mouse Monoclonal Antibody Against Dnmt1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+anti+dnmt1/DNMT3B+Antibody/pmc13123776-57-6-14
    Average 93 stars, based on 1 article reviews
    mouse monoclonal antibody against dnmt1 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    Novus Biologicals mouse monoclonal antibodies
    Epithelial immunohistochemical expression of <t>DNMT1</t> at each exposure time. Main images were magnified at 100x and zoomed sub-image at 400x. Epithelial cells are stained in the nuclei in brown according to exposure period.
    Mouse Monoclonal Antibodies, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+anti+dnmt1/DNMT1+Antibody+(60B1220%2E1)+%5BHRP%5D/pmc12153894-96-8-15
    Average 93 stars, based on 1 article reviews
    mouse monoclonal antibodies - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    Novus Biologicals mouse monoclonal anti dnmt1

    Mouse Monoclonal Anti Dnmt1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+anti+dnmt1/DNMT1+Antibody+(60B1220%2E1)+-+BSA+Free/pmc11956528-26-0-4
    Average 93 stars, based on 1 article reviews
    mouse monoclonal anti dnmt1 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    Novus Biologicals mouse monoclonal anti dnmt1 antibody
    (A–D) To assess the binding of LRP1-ICD (A), and recruitment of epigenetic repressors <t>DNMT1</t> (B), EZH2 (C), or MBD2 (D), to the promoter regions of DKK1 , SPARC , and TIMP2 in EME6/7t EECs treated with ASC-CM, ChIP-qPCR was used at the indicated time points (0, 6, 24, 48, 96, and 168 h). n = 3 technical replicates. Data are represented by mean ± SD. p values were determined using ANOVA test. (E) Bisulfite pyrosequencing analysis targeting the promoter regions of DKK1 , SPARC , and TIMP2 to assess CpG methylation levels in EME6/7t EECs exposed to ASC-CM (experimental duplicates: CM1 and CM2) or control (experimental duplicates: C01 and C02) for 21 days. The green box indicates CpG island, and the short, thick black line over the gene body represents the scale of 200 bp. The thicker, short blue box represents the probed sites. (F) Model for the underlying repressive actions by ASC-CM, which leads to the sequential recruitment of epigenetic repressors and subsequently marks the promoters of DKK1 , SPARC , and TIMP2 for methylation. LRP1-ICD initiates transcriptional repression of these genes. EZH2 and DNMT1 binding then enforces DNA methylation and establishes epigenetic silencing. See also – , and .
    Mouse Monoclonal Anti Dnmt1 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+anti+dnmt1/DNMT1+Antibody+(60B1220%2E1)+-+BSA+Free/pmc11956528-309-48-52
    Average 93 stars, based on 1 article reviews
    mouse monoclonal anti dnmt1 antibody - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    90
    Active Motif antibody anti-dnmt1 antibody (mouse monoclonal)
    ( A ) The expression levels of <t>Dnmt1</t> , Dnmt3a, and Dnmt3l in oocytes were examined using qPCR after the treatment with SQ22536 and forskolin. *p<0.05. Data presented as mean ± SEM; a two-tail t-test was used. p-value presented in the source data. ( B ) The relative expressions of Dnmt1 , Dnmt3a, and Dnmt3l in oocytes were examined using qPCR after the treatment with luzindole and melatonin. *p<0.05. Data presented as mean ± SEM; a two-tail t-test was used. ( C ) After 8-Bromo-cAMP treatment, the relative expression of DNMT3a in oocytes was examined using immunofluorescence and calculated by Image J ( D ) (Control, n=54; 8-Bromo-cAMP, n=70, p=0.002447). **p<0.01. Data presented as mean ± SEM; a two-tail t-test was used. ( E and F ) Treatment with the protein kinase A (PKA) antagonist H 89 2HCL treatment significantly reduced the level of DNMT3A in oocytes examined using immunofluorescence (Control, n=62; H 89 2HCl, n=48, p=0.003922). **p<0.01. Data presented as mean ± SEM; a two-tail t-test was used. ( G and H ) DNMT1 localization in the oocyte nucleus was examined using immunofluorescence after 8-Bromo-cAMP treatment (Control, n=30; 8-Bromo-cAMP, n=31, p=3.136*10 –7 ). ***p<0.001. Data presented as mean ± SEM;a two-tail t-test was used. ( I and J ) The localization of DNMT1 in oocyte nucleus was reduced by the treatment with the PKA antagonist H 89 2HCL (Control, n=22; H 89 2HCl, n=28, p=0.004929). ** p<0.01. Data presented as mean ± SEM; a two-tail t-test was used. Source data are presented in . Figure 7—source data 1. Extended data for .
    Antibody Anti Dnmt1 Antibody (Mouse Monoclonal), supplied by Active Motif, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+anti+dnmt1/dnmt1+antibody/pmc11623932-4-2-7
    Average 90 stars, based on 1 article reviews
    antibody anti-dnmt1 antibody (mouse monoclonal) - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Millipore mouse monoclonal anti-dnmt1
    Measurement of the cofactor of methylation activity (DNMT1and MS) by qRT-PCR and flow cytometery. Positive control increased <t>DNMT1</t> to 7-fold change while other treatment makes significant downregulation (A) . Error bars indicate standard deviation of three independent experiments. The student’s two-tailed t-test was used for statistical analysis. P-value ≤ 0.05 was considered statistically significant. Positive control increased MS to 10-fold change while other treatment makes significant downregulation (B) . Protein expression profile of DNMT1 and MS indicated by red and blue dotes using secondary antibodies Alex Flour-488 and 594, respectively (C) . *statistically significant difference as compared with the controls (P, 0.05 for each). While, ** statistically significant difference as compared with the controls (P, 0.01 for each).
    Mouse Monoclonal Anti Dnmt1, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+anti+dnmt1/anti+dnmt1/pmc10844948-99-15-18
    Average 90 stars, based on 1 article reviews
    mouse monoclonal anti-dnmt1 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    86
    Danaher Inc mouse monoclonal anti dnmt1 antibody
    DENV infection reduces miR-126-3p, increases <t>DNMT1,</t> and reduces GATA-1 expression in Meg-01 cells (A and B) Detection and quantification of miR-126-3p (A) as well as DNMT1, viral NS3, and GATA-1 proteins in Meg-01 cells infected with DENV-2 at an MOI of 1 at different time points by RT-qPCR (A) and immunoblotting (B). Values are means ± SD (n = 4, one-way ANOVA). The ratio of mock infected cells was arbitrarily set to 100 (A). Expression of GAPDH served as the loading control (B). Values shown below the blots are ratios between the intensity of the bands corresponding to DNMT1 or GATA-1 and those corresponding to GAPDH analyzed by densitometry, where the ratio of mock infected cells was set to 1. (C) Immunohistochemical detection (original magnification ×200; scale bar = 100 μm) (left) and quantitation of DNMT1-positive cells (right) in the bone marrow of WT mice treated with either saline or DENV-2 + anti-CD41 at day 4 pi. Values shown are mean ± SD (n = 3, Student’s t test). (D–G) Detection and quantification of miR-126-3p (D), DNMT1 (E), GATA-1 (F), and ProT (G) in Meg-01 cells transduced with LV.miR-126 or LV.miR-Ctrl by RT-qPCR. The ratio of LV.miR-Ctrl-transduced control cells was arbitrarily set to 100. Values shown are mean ± SD (n = 4, Student’s t test).
    Mouse Monoclonal Anti Dnmt1 Antibody, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+anti+dnmt1/pmc10783621-13-0-5
    Average 86 stars, based on 1 article reviews
    mouse monoclonal anti dnmt1 antibody - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    95
    Santa Cruz Biotechnology mouse monoclonal anti dnmt1 antibody
    DENV infection reduces miR-126-3p, increases <t>DNMT1,</t> and reduces GATA-1 expression in Meg-01 cells (A and B) Detection and quantification of miR-126-3p (A) as well as DNMT1, viral NS3, and GATA-1 proteins in Meg-01 cells infected with DENV-2 at an MOI of 1 at different time points by RT-qPCR (A) and immunoblotting (B). Values are means ± SD (n = 4, one-way ANOVA). The ratio of mock infected cells was arbitrarily set to 100 (A). Expression of GAPDH served as the loading control (B). Values shown below the blots are ratios between the intensity of the bands corresponding to DNMT1 or GATA-1 and those corresponding to GAPDH analyzed by densitometry, where the ratio of mock infected cells was set to 1. (C) Immunohistochemical detection (original magnification ×200; scale bar = 100 μm) (left) and quantitation of DNMT1-positive cells (right) in the bone marrow of WT mice treated with either saline or DENV-2 + anti-CD41 at day 4 pi. Values shown are mean ± SD (n = 3, Student’s t test). (D–G) Detection and quantification of miR-126-3p (D), DNMT1 (E), GATA-1 (F), and ProT (G) in Meg-01 cells transduced with LV.miR-126 or LV.miR-Ctrl by RT-qPCR. The ratio of LV.miR-Ctrl-transduced control cells was arbitrarily set to 100. Values shown are mean ± SD (n = 4, Student’s t test).
    Mouse Monoclonal Anti Dnmt1 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+monoclonal+anti+dnmt1/Dnmt1+Antibody/pmc10783621-12-0-5
    Average 95 stars, based on 1 article reviews
    mouse monoclonal anti dnmt1 antibody - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    Image Search Results


    Epithelial immunohistochemical expression of DNMT1 at each exposure time. Main images were magnified at 100x and zoomed sub-image at 400x. Epithelial cells are stained in the nuclei in brown according to exposure period.

    Journal: Journal of Applied Oral Science

    Article Title: DNA methyltransferases expressions in mice tongue exposed to waterpipe smoke

    doi: 10.1590/1678-7765-2025-0665

    Figure Lengend Snippet: Epithelial immunohistochemical expression of DNMT1 at each exposure time. Main images were magnified at 100x and zoomed sub-image at 400x. Epithelial cells are stained in the nuclei in brown according to exposure period.

    Article Snippet: The sections were then incubated with mouse monoclonal antibody against DNMT1 (60B1220.1, 1:1500 dilution, Novus Biologicals, Centennial, EUA) and DNMT3b (NB300-516, 1:500 dilution, Novus Biologicals, Centennial, EUA) at 4°C overnight.

    Techniques: Immunohistochemical staining, Expressing, Staining

    Boxplots showing enzyme expression pattern according to exposure times (in days) on each tongue site for DNMT1 (a) and DNMT3b (b). The graphic presents the variable distribution of our data in a five number summary (minimum, first quartile, mean, upper quartile and maximum); circles=outliers; *=extreme outliers; †=statistically significant difference.

    Journal: Journal of Applied Oral Science

    Article Title: DNA methyltransferases expressions in mice tongue exposed to waterpipe smoke

    doi: 10.1590/1678-7765-2025-0665

    Figure Lengend Snippet: Boxplots showing enzyme expression pattern according to exposure times (in days) on each tongue site for DNMT1 (a) and DNMT3b (b). The graphic presents the variable distribution of our data in a five number summary (minimum, first quartile, mean, upper quartile and maximum); circles=outliers; *=extreme outliers; †=statistically significant difference.

    Article Snippet: The sections were then incubated with mouse monoclonal antibody against DNMT1 (60B1220.1, 1:1500 dilution, Novus Biologicals, Centennial, EUA) and DNMT3b (NB300-516, 1:500 dilution, Novus Biologicals, Centennial, EUA) at 4°C overnight.

    Techniques: Expressing

    Journal: Cell reports

    Article Title: PAI-1 uncouples integrin-β1 from restrain by membrane-bound β-catenin to promote collagen fibril remodeling in obesity-related neoplasms

    doi: 10.1016/j.celrep.2024.114527

    Figure Lengend Snippet:

    Article Snippet: Mouse monoclonal anti-DNMT1 , Novus Biologicals , Cat# NB100-56519; RRID: AB_2093819.

    Techniques: Recombinant, Membrane, Cell Culture, Reverse Transcription, SYBR Green Assay, Clinical Proteomics, Protein Extraction, Extraction, Bicinchoninic Acid Protein Assay, In Situ, Blocking Assay, Migration, shRNA, Control, Software, Pyromark Assay, Western Blot, Simple Western

    (A–D) To assess the binding of LRP1-ICD (A), and recruitment of epigenetic repressors DNMT1 (B), EZH2 (C), or MBD2 (D), to the promoter regions of DKK1 , SPARC , and TIMP2 in EME6/7t EECs treated with ASC-CM, ChIP-qPCR was used at the indicated time points (0, 6, 24, 48, 96, and 168 h). n = 3 technical replicates. Data are represented by mean ± SD. p values were determined using ANOVA test. (E) Bisulfite pyrosequencing analysis targeting the promoter regions of DKK1 , SPARC , and TIMP2 to assess CpG methylation levels in EME6/7t EECs exposed to ASC-CM (experimental duplicates: CM1 and CM2) or control (experimental duplicates: C01 and C02) for 21 days. The green box indicates CpG island, and the short, thick black line over the gene body represents the scale of 200 bp. The thicker, short blue box represents the probed sites. (F) Model for the underlying repressive actions by ASC-CM, which leads to the sequential recruitment of epigenetic repressors and subsequently marks the promoters of DKK1 , SPARC , and TIMP2 for methylation. LRP1-ICD initiates transcriptional repression of these genes. EZH2 and DNMT1 binding then enforces DNA methylation and establishes epigenetic silencing. See also – , and .

    Journal: Cell reports

    Article Title: PAI-1 uncouples integrin-β1 from restrain by membrane-bound β-catenin to promote collagen fibril remodeling in obesity-related neoplasms

    doi: 10.1016/j.celrep.2024.114527

    Figure Lengend Snippet: (A–D) To assess the binding of LRP1-ICD (A), and recruitment of epigenetic repressors DNMT1 (B), EZH2 (C), or MBD2 (D), to the promoter regions of DKK1 , SPARC , and TIMP2 in EME6/7t EECs treated with ASC-CM, ChIP-qPCR was used at the indicated time points (0, 6, 24, 48, 96, and 168 h). n = 3 technical replicates. Data are represented by mean ± SD. p values were determined using ANOVA test. (E) Bisulfite pyrosequencing analysis targeting the promoter regions of DKK1 , SPARC , and TIMP2 to assess CpG methylation levels in EME6/7t EECs exposed to ASC-CM (experimental duplicates: CM1 and CM2) or control (experimental duplicates: C01 and C02) for 21 days. The green box indicates CpG island, and the short, thick black line over the gene body represents the scale of 200 bp. The thicker, short blue box represents the probed sites. (F) Model for the underlying repressive actions by ASC-CM, which leads to the sequential recruitment of epigenetic repressors and subsequently marks the promoters of DKK1 , SPARC , and TIMP2 for methylation. LRP1-ICD initiates transcriptional repression of these genes. EZH2 and DNMT1 binding then enforces DNA methylation and establishes epigenetic silencing. See also – , and .

    Article Snippet: Sonicated DNA fragments (~300–500 bp) were incubated with rabbit monoclonal anti-LRP1-ICD antibody (Abcam, Cat# ab92544), mouse monoclonal anti-YAP1 antibody (Novus Biologicals, Cat# NBP2–22117), rabbit monoclonal anti-Pan-TEAD antibody (Cell Signaling Technology, Cat# 13295S), mouse monoclonal anti-EZH2 antibody (Active Motif, Cat# 39076), goat polyclonal anti-MBD2 antibody (Novus Biologicals, Cat# NB100–55415), mouse monoclonal anti-DNMT1 antibody (Novus Biologicals, Cat# NB100–56519), normal goat IgG antibody (Abcam, Cat# ab37373), normal mouse IgG antibody (Millipore, Cat# NI03–100UG) or normal rabbit IgG antibody (Pierce Magnetic ChIP Kit, ThermoFisher Scientific, Cat# 26157) overnight at 4°C.

    Techniques: Binding Assay, ChIP-qPCR, CpG Methylation Assay, Control, Methylation, DNA Methylation Assay

    Journal: Cell reports

    Article Title: PAI-1 uncouples integrin-β1 from restrain by membrane-bound β-catenin to promote collagen fibril remodeling in obesity-related neoplasms

    doi: 10.1016/j.celrep.2024.114527

    Figure Lengend Snippet:

    Article Snippet: Sonicated DNA fragments (~300–500 bp) were incubated with rabbit monoclonal anti-LRP1-ICD antibody (Abcam, Cat# ab92544), mouse monoclonal anti-YAP1 antibody (Novus Biologicals, Cat# NBP2–22117), rabbit monoclonal anti-Pan-TEAD antibody (Cell Signaling Technology, Cat# 13295S), mouse monoclonal anti-EZH2 antibody (Active Motif, Cat# 39076), goat polyclonal anti-MBD2 antibody (Novus Biologicals, Cat# NB100–55415), mouse monoclonal anti-DNMT1 antibody (Novus Biologicals, Cat# NB100–56519), normal goat IgG antibody (Abcam, Cat# ab37373), normal mouse IgG antibody (Millipore, Cat# NI03–100UG) or normal rabbit IgG antibody (Pierce Magnetic ChIP Kit, ThermoFisher Scientific, Cat# 26157) overnight at 4°C.

    Techniques: Recombinant, Membrane, Cell Culture, Reverse Transcription, SYBR Green Assay, Clinical Proteomics, Protein Extraction, Extraction, Bicinchoninic Acid Protein Assay, In Situ, Blocking Assay, Migration, shRNA, Control, Software, Pyromark Assay, Western Blot, Simple Western

    ( A ) The expression levels of Dnmt1 , Dnmt3a, and Dnmt3l in oocytes were examined using qPCR after the treatment with SQ22536 and forskolin. *p<0.05. Data presented as mean ± SEM; a two-tail t-test was used. p-value presented in the source data. ( B ) The relative expressions of Dnmt1 , Dnmt3a, and Dnmt3l in oocytes were examined using qPCR after the treatment with luzindole and melatonin. *p<0.05. Data presented as mean ± SEM; a two-tail t-test was used. ( C ) After 8-Bromo-cAMP treatment, the relative expression of DNMT3a in oocytes was examined using immunofluorescence and calculated by Image J ( D ) (Control, n=54; 8-Bromo-cAMP, n=70, p=0.002447). **p<0.01. Data presented as mean ± SEM; a two-tail t-test was used. ( E and F ) Treatment with the protein kinase A (PKA) antagonist H 89 2HCL treatment significantly reduced the level of DNMT3A in oocytes examined using immunofluorescence (Control, n=62; H 89 2HCl, n=48, p=0.003922). **p<0.01. Data presented as mean ± SEM; a two-tail t-test was used. ( G and H ) DNMT1 localization in the oocyte nucleus was examined using immunofluorescence after 8-Bromo-cAMP treatment (Control, n=30; 8-Bromo-cAMP, n=31, p=3.136*10 –7 ). ***p<0.001. Data presented as mean ± SEM;a two-tail t-test was used. ( I and J ) The localization of DNMT1 in oocyte nucleus was reduced by the treatment with the PKA antagonist H 89 2HCL (Control, n=22; H 89 2HCl, n=28, p=0.004929). ** p<0.01. Data presented as mean ± SEM; a two-tail t-test was used. Source data are presented in . Figure 7—source data 1. Extended data for .

    Journal: eLife

    Article Title: Maternal obesity may disrupt offspring metabolism by inducing oocyte genome hyper-methylation via increased DNMTs

    doi: 10.7554/eLife.97507

    Figure Lengend Snippet: ( A ) The expression levels of Dnmt1 , Dnmt3a, and Dnmt3l in oocytes were examined using qPCR after the treatment with SQ22536 and forskolin. *p<0.05. Data presented as mean ± SEM; a two-tail t-test was used. p-value presented in the source data. ( B ) The relative expressions of Dnmt1 , Dnmt3a, and Dnmt3l in oocytes were examined using qPCR after the treatment with luzindole and melatonin. *p<0.05. Data presented as mean ± SEM; a two-tail t-test was used. ( C ) After 8-Bromo-cAMP treatment, the relative expression of DNMT3a in oocytes was examined using immunofluorescence and calculated by Image J ( D ) (Control, n=54; 8-Bromo-cAMP, n=70, p=0.002447). **p<0.01. Data presented as mean ± SEM; a two-tail t-test was used. ( E and F ) Treatment with the protein kinase A (PKA) antagonist H 89 2HCL treatment significantly reduced the level of DNMT3A in oocytes examined using immunofluorescence (Control, n=62; H 89 2HCl, n=48, p=0.003922). **p<0.01. Data presented as mean ± SEM; a two-tail t-test was used. ( G and H ) DNMT1 localization in the oocyte nucleus was examined using immunofluorescence after 8-Bromo-cAMP treatment (Control, n=30; 8-Bromo-cAMP, n=31, p=3.136*10 –7 ). ***p<0.001. Data presented as mean ± SEM;a two-tail t-test was used. ( I and J ) The localization of DNMT1 in oocyte nucleus was reduced by the treatment with the PKA antagonist H 89 2HCL (Control, n=22; H 89 2HCl, n=28, p=0.004929). ** p<0.01. Data presented as mean ± SEM; a two-tail t-test was used. Source data are presented in . Figure 7—source data 1. Extended data for .

    Article Snippet: Antibody , Anti-DNMT1 antibody (Mouse Monoclonal) , Active motif , 39204 , IF(1:200).

    Techniques: Expressing, Immunofluorescence, Control

    ( A ) The relative expression of Dnmt1 , Dnmt3a, and Dnmt3l in HFD oocytes was examined using qPCR. *p<0.05; **p<0.01. Data presented as mean ± SD; two-tail t-test used. p-value presented in the source data. ( B ) The concentration of cAMP in HFD oocytes was examined using ELISA. **p<0.01. Data presented as mean ± SEM; a two-tail t-test was used, n: CD=6, HFD = 3, p=0.004375.( C ) The relative expressions CREB1 and CREM in HFD oocytes were tested using qPCR. *p<0.05; **p<0.01. Data presented as mean ± SD; a two-tail t-test was used. Replicated three times for each gene, and p value presented in the source data.( D and E ) The level of pCREB1 in oocytes was examined using immunofluorescence, and the relative fluorescence intensity was calculated by Image J ( E ) (CD, n=69; HFD, n=49, p=3.326×10 –16 ; HFD + melatonin, n=61, p=8.997×10 –20 ). HFD, oocytes from obese mice; CD, oocytes from control mice; HFD + melatonin, oocytes from obese mice treated with exogenous melatonin. *p<0.05; ***p<0.001. Data presented as mean ± SEM; a two-tail t-test was used. ( F and G ) Treatment with the PKA antagonist H89 2HCL reduced the methylation level of HFD oocytes (CD, n=48; HFD, n=31, p=1.674*10 –13 ; HFD + H 89 2HCl, n=27, p=0.00324). ** p<0.01; *** p<0.001. Data presented as mean ± SEM; a two-tail t-test was used. ( H and I ) The level of pCREB1 in HFD oocytes was also decreased by the treatment with the protein kinase A (PKA) antagonist H89 2HCL (CD, n=17; HFD, n=17, p=0.006249; HFD +H 89 2HCl, n=22, p=0.027987). *p<0.05; **p<0.01; ns, no statistical significance between groups. Data presented as mean ± SEM; a two-tail t-test was used. ( J and K ) Treatment with the PKA antagonist H89 2HCL reduced the localization of DNMT1 in HFD oocytes (CD, n=24; HFD, n=29, p=6.214×10 –6 ; HFD + H 89 2HCl, n=25, p0.003147). **p<0.01; ***p<0.001; ns, no statistical significance between groups. Data presented as mean ± SEM; a two-tail t-test was used. Source data are presented in . Figure 8—source data 1. Extended data for .

    Journal: eLife

    Article Title: Maternal obesity may disrupt offspring metabolism by inducing oocyte genome hyper-methylation via increased DNMTs

    doi: 10.7554/eLife.97507

    Figure Lengend Snippet: ( A ) The relative expression of Dnmt1 , Dnmt3a, and Dnmt3l in HFD oocytes was examined using qPCR. *p<0.05; **p<0.01. Data presented as mean ± SD; two-tail t-test used. p-value presented in the source data. ( B ) The concentration of cAMP in HFD oocytes was examined using ELISA. **p<0.01. Data presented as mean ± SEM; a two-tail t-test was used, n: CD=6, HFD = 3, p=0.004375.( C ) The relative expressions CREB1 and CREM in HFD oocytes were tested using qPCR. *p<0.05; **p<0.01. Data presented as mean ± SD; a two-tail t-test was used. Replicated three times for each gene, and p value presented in the source data.( D and E ) The level of pCREB1 in oocytes was examined using immunofluorescence, and the relative fluorescence intensity was calculated by Image J ( E ) (CD, n=69; HFD, n=49, p=3.326×10 –16 ; HFD + melatonin, n=61, p=8.997×10 –20 ). HFD, oocytes from obese mice; CD, oocytes from control mice; HFD + melatonin, oocytes from obese mice treated with exogenous melatonin. *p<0.05; ***p<0.001. Data presented as mean ± SEM; a two-tail t-test was used. ( F and G ) Treatment with the PKA antagonist H89 2HCL reduced the methylation level of HFD oocytes (CD, n=48; HFD, n=31, p=1.674*10 –13 ; HFD + H 89 2HCl, n=27, p=0.00324). ** p<0.01; *** p<0.001. Data presented as mean ± SEM; a two-tail t-test was used. ( H and I ) The level of pCREB1 in HFD oocytes was also decreased by the treatment with the protein kinase A (PKA) antagonist H89 2HCL (CD, n=17; HFD, n=17, p=0.006249; HFD +H 89 2HCl, n=22, p=0.027987). *p<0.05; **p<0.01; ns, no statistical significance between groups. Data presented as mean ± SEM; a two-tail t-test was used. ( J and K ) Treatment with the PKA antagonist H89 2HCL reduced the localization of DNMT1 in HFD oocytes (CD, n=24; HFD, n=29, p=6.214×10 –6 ; HFD + H 89 2HCl, n=25, p0.003147). **p<0.01; ***p<0.001; ns, no statistical significance between groups. Data presented as mean ± SEM; a two-tail t-test was used. Source data are presented in . Figure 8—source data 1. Extended data for .

    Article Snippet: Antibody , Anti-DNMT1 antibody (Mouse Monoclonal) , Active motif , 39204 , IF(1:200).

    Techniques: Expressing, Concentration Assay, Enzyme-linked Immunosorbent Assay, Immunofluorescence, Fluorescence, Control, Methylation

    Journal: eLife

    Article Title: Maternal obesity may disrupt offspring metabolism by inducing oocyte genome hyper-methylation via increased DNMTs

    doi: 10.7554/eLife.97507

    Figure Lengend Snippet:

    Article Snippet: Antibody , Anti-DNMT1 antibody (Mouse Monoclonal) , Active motif , 39204 , IF(1:200).

    Techniques: Sequencing, Enzyme-linked Immunosorbent Assay, Software

    Measurement of the cofactor of methylation activity (DNMT1and MS) by qRT-PCR and flow cytometery. Positive control increased DNMT1 to 7-fold change while other treatment makes significant downregulation (A) . Error bars indicate standard deviation of three independent experiments. The student’s two-tailed t-test was used for statistical analysis. P-value ≤ 0.05 was considered statistically significant. Positive control increased MS to 10-fold change while other treatment makes significant downregulation (B) . Protein expression profile of DNMT1 and MS indicated by red and blue dotes using secondary antibodies Alex Flour-488 and 594, respectively (C) . *statistically significant difference as compared with the controls (P, 0.05 for each). While, ** statistically significant difference as compared with the controls (P, 0.01 for each).

    Journal: Frontiers in Immunology

    Article Title: Amelioration effect of 18β-Glycyrrhetinic acid on methylation inhibitors in hepatocarcinogenesis -induced by diethylnitrosamine

    doi: 10.3389/fimmu.2023.1206990

    Figure Lengend Snippet: Measurement of the cofactor of methylation activity (DNMT1and MS) by qRT-PCR and flow cytometery. Positive control increased DNMT1 to 7-fold change while other treatment makes significant downregulation (A) . Error bars indicate standard deviation of three independent experiments. The student’s two-tailed t-test was used for statistical analysis. P-value ≤ 0.05 was considered statistically significant. Positive control increased MS to 10-fold change while other treatment makes significant downregulation (B) . Protein expression profile of DNMT1 and MS indicated by red and blue dotes using secondary antibodies Alex Flour-488 and 594, respectively (C) . *statistically significant difference as compared with the controls (P, 0.05 for each). While, ** statistically significant difference as compared with the controls (P, 0.01 for each).

    Article Snippet: The same procedures were considered for staining DNMT1, MS, NFkB, and STAT3 using specific antibodies: mouse monoclonal anti-DNMT1 (Sigma-Aldrich, Germany), rabbit monoclonal anti-MS (Sigma-Aldrich, Germany), mouse monoclonal anti-NFkB (Sigma-Aldrich, Germany), and rabbit monoclonal anti-STAT3 (Sigma-Aldrich, Germany), respectively.

    Techniques: Methylation, Activity Assay, Quantitative RT-PCR, Positive Control, Standard Deviation, Two Tailed Test, Expressing

    DENV infection reduces miR-126-3p, increases DNMT1, and reduces GATA-1 expression in Meg-01 cells (A and B) Detection and quantification of miR-126-3p (A) as well as DNMT1, viral NS3, and GATA-1 proteins in Meg-01 cells infected with DENV-2 at an MOI of 1 at different time points by RT-qPCR (A) and immunoblotting (B). Values are means ± SD (n = 4, one-way ANOVA). The ratio of mock infected cells was arbitrarily set to 100 (A). Expression of GAPDH served as the loading control (B). Values shown below the blots are ratios between the intensity of the bands corresponding to DNMT1 or GATA-1 and those corresponding to GAPDH analyzed by densitometry, where the ratio of mock infected cells was set to 1. (C) Immunohistochemical detection (original magnification ×200; scale bar = 100 μm) (left) and quantitation of DNMT1-positive cells (right) in the bone marrow of WT mice treated with either saline or DENV-2 + anti-CD41 at day 4 pi. Values shown are mean ± SD (n = 3, Student’s t test). (D–G) Detection and quantification of miR-126-3p (D), DNMT1 (E), GATA-1 (F), and ProT (G) in Meg-01 cells transduced with LV.miR-126 or LV.miR-Ctrl by RT-qPCR. The ratio of LV.miR-Ctrl-transduced control cells was arbitrarily set to 100. Values shown are mean ± SD (n = 4, Student’s t test).

    Journal: iScience

    Article Title: Prothymosin α accelerates dengue virus-induced thrombocytopenia

    doi: 10.1016/j.isci.2023.108422

    Figure Lengend Snippet: DENV infection reduces miR-126-3p, increases DNMT1, and reduces GATA-1 expression in Meg-01 cells (A and B) Detection and quantification of miR-126-3p (A) as well as DNMT1, viral NS3, and GATA-1 proteins in Meg-01 cells infected with DENV-2 at an MOI of 1 at different time points by RT-qPCR (A) and immunoblotting (B). Values are means ± SD (n = 4, one-way ANOVA). The ratio of mock infected cells was arbitrarily set to 100 (A). Expression of GAPDH served as the loading control (B). Values shown below the blots are ratios between the intensity of the bands corresponding to DNMT1 or GATA-1 and those corresponding to GAPDH analyzed by densitometry, where the ratio of mock infected cells was set to 1. (C) Immunohistochemical detection (original magnification ×200; scale bar = 100 μm) (left) and quantitation of DNMT1-positive cells (right) in the bone marrow of WT mice treated with either saline or DENV-2 + anti-CD41 at day 4 pi. Values shown are mean ± SD (n = 3, Student’s t test). (D–G) Detection and quantification of miR-126-3p (D), DNMT1 (E), GATA-1 (F), and ProT (G) in Meg-01 cells transduced with LV.miR-126 or LV.miR-Ctrl by RT-qPCR. The ratio of LV.miR-Ctrl-transduced control cells was arbitrarily set to 100. Values shown are mean ± SD (n = 4, Student’s t test).

    Article Snippet: Mouse monoclonal anti-Dnmt1 antibody , Abcam , Cat #ab13537; RRID: AB_300438.

    Techniques: Infection, Expressing, Quantitative RT-PCR, Western Blot, Immunohistochemistry, Quantitation Assay, Saline, Transduction

    DNMT1 negatively regulates GATA-1 expression, and GATA-1 also negatively regulates ProT expression (A) Detection (left) and quantification (right) of GATA-1 and viral NS3 in DENV-infected Meg-01 cells treated with 1, 2, or 5 μM of the DNMT1 inhibitor 5-AZA-2′-deoxycytidine (5′-Aza-dc) for 72 h. Expression of β-actin served as the loading control. The immunoblot is from one representative experiment of three (left). Values shown are ratios between the intensity of the bands corresponding to GATA-1 and those corresponding to β-actin analyzed by densitometry, where the ratio of mock infected cells was set to 1 (right). Values shown are mean ± SD (n = 3, one-way ANOVA). (B) ChIP assay showing a 2.5-fold increase in the binding of DNMT1 to the GATA-1 promoter region in Meg-01 cells after infection with DENV-2 at an MOI of 1 for 3 days. Cross-linked chromatin was immunoprecipitated with anti-DNMT-1 or anti-IgG antibody combined with protein G agarose beads, followed by PCR amplification of the GATA-1 promoter. The ratio shown below the images is normalized to the amount of the input. (C) The PTMA promoter activity assessed in 293T cells 48 h after cotransfection with 1 μg of pGL3-pProT-Luc and various doses of pSin4-EF1a-GATA-1-IRES-Puro (upper panel). The total amount of plasmid DNA for transfection was kept constant by the addition of a control plasmid. Validation of GATA-1 expression in a dose-dependent manner by immunoblotting (lower panel). Expression of β-actin served as the loading control. Values shown are means ± SD (n = 3, one-way ANOVA). (D) Expression of ProT (upper panel) and validation of knockdown of GATA-1 expression (lower panel) in GATA-1 knockdown Meg-01 and control cells. Meg-01 cells were transduced with lentiviral vectors encoding shRNAs specific to GATA-1 (shGATA-1-358 and shGATA-1-359) or LacZ (control). Expression of β-actin or GAPDH served as the loading control. Values shown below the blots are ratios between the intensity of the bands corresponding to ProT or GATA-1 and those corresponding to β-actin or GAPDH analyzed by densitometry, where the ratio of mock infected cells was set to 1.

    Journal: iScience

    Article Title: Prothymosin α accelerates dengue virus-induced thrombocytopenia

    doi: 10.1016/j.isci.2023.108422

    Figure Lengend Snippet: DNMT1 negatively regulates GATA-1 expression, and GATA-1 also negatively regulates ProT expression (A) Detection (left) and quantification (right) of GATA-1 and viral NS3 in DENV-infected Meg-01 cells treated with 1, 2, or 5 μM of the DNMT1 inhibitor 5-AZA-2′-deoxycytidine (5′-Aza-dc) for 72 h. Expression of β-actin served as the loading control. The immunoblot is from one representative experiment of three (left). Values shown are ratios between the intensity of the bands corresponding to GATA-1 and those corresponding to β-actin analyzed by densitometry, where the ratio of mock infected cells was set to 1 (right). Values shown are mean ± SD (n = 3, one-way ANOVA). (B) ChIP assay showing a 2.5-fold increase in the binding of DNMT1 to the GATA-1 promoter region in Meg-01 cells after infection with DENV-2 at an MOI of 1 for 3 days. Cross-linked chromatin was immunoprecipitated with anti-DNMT-1 or anti-IgG antibody combined with protein G agarose beads, followed by PCR amplification of the GATA-1 promoter. The ratio shown below the images is normalized to the amount of the input. (C) The PTMA promoter activity assessed in 293T cells 48 h after cotransfection with 1 μg of pGL3-pProT-Luc and various doses of pSin4-EF1a-GATA-1-IRES-Puro (upper panel). The total amount of plasmid DNA for transfection was kept constant by the addition of a control plasmid. Validation of GATA-1 expression in a dose-dependent manner by immunoblotting (lower panel). Expression of β-actin served as the loading control. Values shown are means ± SD (n = 3, one-way ANOVA). (D) Expression of ProT (upper panel) and validation of knockdown of GATA-1 expression (lower panel) in GATA-1 knockdown Meg-01 and control cells. Meg-01 cells were transduced with lentiviral vectors encoding shRNAs specific to GATA-1 (shGATA-1-358 and shGATA-1-359) or LacZ (control). Expression of β-actin or GAPDH served as the loading control. Values shown below the blots are ratios between the intensity of the bands corresponding to ProT or GATA-1 and those corresponding to β-actin or GAPDH analyzed by densitometry, where the ratio of mock infected cells was set to 1.

    Article Snippet: Mouse monoclonal anti-Dnmt1 antibody , Abcam , Cat #ab13537; RRID: AB_300438.

    Techniques: Expressing, Infection, Western Blot, Binding Assay, Immunoprecipitation, Amplification, Activity Assay, Cotransfection, Plasmid Preparation, Transfection, Transduction

    Journal: iScience

    Article Title: Prothymosin α accelerates dengue virus-induced thrombocytopenia

    doi: 10.1016/j.isci.2023.108422

    Figure Lengend Snippet:

    Article Snippet: Mouse monoclonal anti-Dnmt1 antibody , Abcam , Cat #ab13537; RRID: AB_300438.

    Techniques: Recombinant, Stripping Membranes, Isolation, TaqMan microRNA Assay, Plasmid Preparation, shRNA, Software, RNA Expression, Knock-Out, Microarray

    DENV infection reduces miR-126-3p, increases DNMT1, and reduces GATA-1 expression in Meg-01 cells (A and B) Detection and quantification of miR-126-3p (A) as well as DNMT1, viral NS3, and GATA-1 proteins in Meg-01 cells infected with DENV-2 at an MOI of 1 at different time points by RT-qPCR (A) and immunoblotting (B). Values are means ± SD (n = 4, one-way ANOVA). The ratio of mock infected cells was arbitrarily set to 100 (A). Expression of GAPDH served as the loading control (B). Values shown below the blots are ratios between the intensity of the bands corresponding to DNMT1 or GATA-1 and those corresponding to GAPDH analyzed by densitometry, where the ratio of mock infected cells was set to 1. (C) Immunohistochemical detection (original magnification ×200; scale bar = 100 μm) (left) and quantitation of DNMT1-positive cells (right) in the bone marrow of WT mice treated with either saline or DENV-2 + anti-CD41 at day 4 pi. Values shown are mean ± SD (n = 3, Student’s t test). (D–G) Detection and quantification of miR-126-3p (D), DNMT1 (E), GATA-1 (F), and ProT (G) in Meg-01 cells transduced with LV.miR-126 or LV.miR-Ctrl by RT-qPCR. The ratio of LV.miR-Ctrl-transduced control cells was arbitrarily set to 100. Values shown are mean ± SD (n = 4, Student’s t test).

    Journal: iScience

    Article Title: Prothymosin α accelerates dengue virus-induced thrombocytopenia

    doi: 10.1016/j.isci.2023.108422

    Figure Lengend Snippet: DENV infection reduces miR-126-3p, increases DNMT1, and reduces GATA-1 expression in Meg-01 cells (A and B) Detection and quantification of miR-126-3p (A) as well as DNMT1, viral NS3, and GATA-1 proteins in Meg-01 cells infected with DENV-2 at an MOI of 1 at different time points by RT-qPCR (A) and immunoblotting (B). Values are means ± SD (n = 4, one-way ANOVA). The ratio of mock infected cells was arbitrarily set to 100 (A). Expression of GAPDH served as the loading control (B). Values shown below the blots are ratios between the intensity of the bands corresponding to DNMT1 or GATA-1 and those corresponding to GAPDH analyzed by densitometry, where the ratio of mock infected cells was set to 1. (C) Immunohistochemical detection (original magnification ×200; scale bar = 100 μm) (left) and quantitation of DNMT1-positive cells (right) in the bone marrow of WT mice treated with either saline or DENV-2 + anti-CD41 at day 4 pi. Values shown are mean ± SD (n = 3, Student’s t test). (D–G) Detection and quantification of miR-126-3p (D), DNMT1 (E), GATA-1 (F), and ProT (G) in Meg-01 cells transduced with LV.miR-126 or LV.miR-Ctrl by RT-qPCR. The ratio of LV.miR-Ctrl-transduced control cells was arbitrarily set to 100. Values shown are mean ± SD (n = 4, Student’s t test).

    Article Snippet: Mouse monoclonal anti-Dnmt1 antibody , Santa Cruz Biotechnology , Cat #sc-271729; RRID: AB_10710384.

    Techniques: Infection, Expressing, Quantitative RT-PCR, Western Blot, Control, Immunohistochemical staining, Quantitation Assay, Saline, Transduction

    DNMT1 negatively regulates GATA-1 expression, and GATA-1 also negatively regulates ProT expression (A) Detection (left) and quantification (right) of GATA-1 and viral NS3 in DENV-infected Meg-01 cells treated with 1, 2, or 5 μM of the DNMT1 inhibitor 5-AZA-2′-deoxycytidine (5′-Aza-dc) for 72 h. Expression of β-actin served as the loading control. The immunoblot is from one representative experiment of three (left). Values shown are ratios between the intensity of the bands corresponding to GATA-1 and those corresponding to β-actin analyzed by densitometry, where the ratio of mock infected cells was set to 1 (right). Values shown are mean ± SD (n = 3, one-way ANOVA). (B) ChIP assay showing a 2.5-fold increase in the binding of DNMT1 to the GATA-1 promoter region in Meg-01 cells after infection with DENV-2 at an MOI of 1 for 3 days. Cross-linked chromatin was immunoprecipitated with anti-DNMT-1 or anti-IgG antibody combined with protein G agarose beads, followed by PCR amplification of the GATA-1 promoter. The ratio shown below the images is normalized to the amount of the input. (C) The PTMA promoter activity assessed in 293T cells 48 h after cotransfection with 1 μg of pGL3-pProT-Luc and various doses of pSin4-EF1a-GATA-1-IRES-Puro (upper panel). The total amount of plasmid DNA for transfection was kept constant by the addition of a control plasmid. Validation of GATA-1 expression in a dose-dependent manner by immunoblotting (lower panel). Expression of β-actin served as the loading control. Values shown are means ± SD (n = 3, one-way ANOVA). (D) Expression of ProT (upper panel) and validation of knockdown of GATA-1 expression (lower panel) in GATA-1 knockdown Meg-01 and control cells. Meg-01 cells were transduced with lentiviral vectors encoding shRNAs specific to GATA-1 (shGATA-1-358 and shGATA-1-359) or LacZ (control). Expression of β-actin or GAPDH served as the loading control. Values shown below the blots are ratios between the intensity of the bands corresponding to ProT or GATA-1 and those corresponding to β-actin or GAPDH analyzed by densitometry, where the ratio of mock infected cells was set to 1.

    Journal: iScience

    Article Title: Prothymosin α accelerates dengue virus-induced thrombocytopenia

    doi: 10.1016/j.isci.2023.108422

    Figure Lengend Snippet: DNMT1 negatively regulates GATA-1 expression, and GATA-1 also negatively regulates ProT expression (A) Detection (left) and quantification (right) of GATA-1 and viral NS3 in DENV-infected Meg-01 cells treated with 1, 2, or 5 μM of the DNMT1 inhibitor 5-AZA-2′-deoxycytidine (5′-Aza-dc) for 72 h. Expression of β-actin served as the loading control. The immunoblot is from one representative experiment of three (left). Values shown are ratios between the intensity of the bands corresponding to GATA-1 and those corresponding to β-actin analyzed by densitometry, where the ratio of mock infected cells was set to 1 (right). Values shown are mean ± SD (n = 3, one-way ANOVA). (B) ChIP assay showing a 2.5-fold increase in the binding of DNMT1 to the GATA-1 promoter region in Meg-01 cells after infection with DENV-2 at an MOI of 1 for 3 days. Cross-linked chromatin was immunoprecipitated with anti-DNMT-1 or anti-IgG antibody combined with protein G agarose beads, followed by PCR amplification of the GATA-1 promoter. The ratio shown below the images is normalized to the amount of the input. (C) The PTMA promoter activity assessed in 293T cells 48 h after cotransfection with 1 μg of pGL3-pProT-Luc and various doses of pSin4-EF1a-GATA-1-IRES-Puro (upper panel). The total amount of plasmid DNA for transfection was kept constant by the addition of a control plasmid. Validation of GATA-1 expression in a dose-dependent manner by immunoblotting (lower panel). Expression of β-actin served as the loading control. Values shown are means ± SD (n = 3, one-way ANOVA). (D) Expression of ProT (upper panel) and validation of knockdown of GATA-1 expression (lower panel) in GATA-1 knockdown Meg-01 and control cells. Meg-01 cells were transduced with lentiviral vectors encoding shRNAs specific to GATA-1 (shGATA-1-358 and shGATA-1-359) or LacZ (control). Expression of β-actin or GAPDH served as the loading control. Values shown below the blots are ratios between the intensity of the bands corresponding to ProT or GATA-1 and those corresponding to β-actin or GAPDH analyzed by densitometry, where the ratio of mock infected cells was set to 1.

    Article Snippet: Mouse monoclonal anti-Dnmt1 antibody , Santa Cruz Biotechnology , Cat #sc-271729; RRID: AB_10710384.

    Techniques: Expressing, Infection, Control, Western Blot, Binding Assay, Immunoprecipitation, Amplification, Activity Assay, Cotransfection, Plasmid Preparation, Transfection, Biomarker Discovery, Knockdown, Transduction

    Journal: iScience

    Article Title: Prothymosin α accelerates dengue virus-induced thrombocytopenia

    doi: 10.1016/j.isci.2023.108422

    Figure Lengend Snippet:

    Article Snippet: Mouse monoclonal anti-Dnmt1 antibody , Santa Cruz Biotechnology , Cat #sc-271729; RRID: AB_10710384.

    Techniques: Recombinant, Stripping Membranes, Isolation, Reverse Transcription, TaqMan microRNA Assay, Plasmid Preparation, shRNA, Software, RNA Expression, Knock-Out, Microarray